Rat anti Dog CD8:RPE

BioVenic can offer you a wide range of high quality products.

Rat anti Dog CD8:RPE
Products Name
Rat anti Dog CD8:RPE
Cat.No.
CDMA0065
Size
Qty
Add to Cart
Inquiry

Overview

Description:
Rat anti dog CD8 antibody, clone YCATE55.9 was clustered as Canine CD8 in the First Canine Leukocyte Antigen Workshop. YCATE55.9 reacts with a rat cell line transfected with cDNA for canine CD8α and blocks MHC class I dependant T-cell responses in vitro and in vivo .

Rat anti dog CD8, clone YCATE55.9 has been shown to deplete circulating CD8+ T cells when administered to dogs in vivo. Reduced levels of circulating CD8+ T cells has been associated with decreased survival times for dogs with osteosarcoma.
Product Form:
Purified IgG conjugated to R. Phycoerythrin (RPE) - lyophilized.
Reconstitution:
Reconstitute with 1ml distilled water.
Preparation:
Purified IgG prepared by affinity chromatography on protein G from tissue culture supernatant.
Buffer :
Phosphate buffered saline.
Preservative Stabilisers:
0.09% Sodium azide.
1% Bovine serum albumin.
5% Sucrose.
Immunogen:
Canine CD8 alpha chimaeric human IgG1 Fc fusion protein.
Fusion Partners:
Spleen cells from immunised DA rat were fused with cells of the Y3/Ag1.2.3 rat myeloma cell line.
Excitation Max (nm):
RPE 488 nm laser: 496.
Emission Max (nm):
RPE 488 nm laser: 578.
Regulatory:
For research purposes only.
Guarantee:
12 months from date of despatch.
Application:
Flow cytometry: use 10 µl of the suggested working dilution to label 106 cells in 100 µl.
Storage:
Prior to reconstitution store at +4°C. Following reconstitution store at +4°C.
Note:
DO NOT FREEZE. This product should be stored undiluted. This product is photosensitive and should be protected from light. Should this product contain a precipitate we recommend microcentrifugation before use.
Product Type:
Monoclonal antibody
Clone:
YCATE55.9
Isotype:
IgG1
Specificity:
CD8
Target:
Dog

Leave Your Message Here

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.